Clinical Trial Update: Bevacizumab and Bortezomib in Patients With Advanced Malignancy [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the combination of Bevacizumab and Bortezomib in patients with advanced malignancies, including lymphoma, multiple myeloma, and sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Solid Tumors

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Bortezomib (Velcade) (Bortezomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignancy, Lymphoma | Phase 1 | Status: COMPLETED